IFN - lambda 2 human, ;, recombinant, exprimé en E. coli, > = 98 %( SDS-PAGE) ,> = 98 %( HPLC ),testé sur la culture cellulaire

Code: srp3060-20ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

IFN lambda-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN...


en savoir plus

Votre prix
$398.97 20UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

IFN lambda-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas uses a distinct receptor system composed of an IFN-lambdaR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces antiviral defense similar but distinct than the type I Interferons. (Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-l2 is a 19.6 kDa protein containing 174 amino acid residues.

Physical form

Lyophilized from 10 mM Acetic Acid.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.5-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

Sequence

PVARLHGALP DARGCHIAQF KSLSPQELQA FKRAKDALEE SLLLKDCRCH SRLFPRTWDL RQLQVRERPM ALEAELALTL KVLEATADTD PALVDVLDQP LHTLHHILSQ FRACIQPQPT AGPRTRGRLH HWLYRLQEAP KKESPGCLEA SVTFNLFRLL TRDLNCVASG DLCV

assay≥98% (SDS-PAGE), ≥98% (HPLC)
biological sourcehuman
colorwhite to off-white
formlyophilized
Gene Informationhuman ... IL28A(282616)
impurities﹤0.1 EU/µg endotoxin, tested
mol wt19.6 kDa
packagingpkg of 20 µg
recombinantexpressed in E. coli
shipped inwet ice
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.Q8IZJ0
Ce produit répond aux critères suivants: